• Je něco špatně v tomto záznamu ?

Chemical aspects of pharmacological prophylaxis against nerve agent poisoning

J. Bajgar, J. Fusek, J. Kassa, K. Kuča, D. Jun

. 2009 ; 16 (23) : 2977-2986.

Jazyk angličtina Země Nizozemsko

Typ dokumentu přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc11022985

Prophylactic approaches against intoxication with organophosphates (OP)/nerve agents can be based on following principles: keeping acetylcholinesterase (AChE), the key enzyme for toxic action of OP/nerve agents, intact (protection of cholinesterases) is a basic requirement for effective prophylaxis. It can be reached using simple chemicals such as reversible inhibitors (preferably carbamates), which are able to inhibit AChE reversibly. AChE inhibited by carbamates is resistant to OP/nerve agent inhibition. After spontaneous recovery of the activity, normal AChE serves as a source of the active enzyme. Detoxification is realised by administration of the enzymes splitting the OP or exploitating specific enzymes (cholinesterases). OP/nerve agent is bound to the exogenously administered proteins (enzymes) and, thus, the agent level in the organism is decreased ("scavenger" effect). The antidotes currently used for the treatment of OP poisoning (also simple chemicals) can be tested as prophylactics. This principle can be considered as a treatment "in advance". The problem with their use is the timing, duration and achievement of sufficient levels of these antidotes after the administration. At present, PYRIDOSTIGMINE seems to be common prophylactic antidote; prophylactics PANPAL (tablets with pyridostigmine, trihexyphenidyle and benactyzine), TRANSANT (transdermal patch containing HI-6) are other means introduced into different armies as prophylactics. Future development will be focused on scavengers (cholinesterases and other enzymes) acting before the binding of nerve agent to the target sites, and on other drugs reversible cholinesterase inhibitors (e.g. huperzine A, physostigmine, acridine derivatives etc.) including non-traditional routes of administration.

Citace poskytuje Crossref.org

000      
03603naa 2200433 a 4500
001      
bmc11022985
003      
CZ-PrNML
005      
20121127124104.0
008      
110801s2009 ne e Eng||
009      
AR
024    __
$a 10.2174/092986709788803088 $2 doi
035    __
$a (PubMed)19689278
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Bajgar, Jiří, $d 1944- $7 js20020122033
245    10
$a Chemical aspects of pharmacological prophylaxis against nerve agent poisoning / $c J. Bajgar, J. Fusek, J. Kassa, K. Kuča, D. Jun
314    __
$a Department of Toxicology, Faculty of Military Health Sciences, University of Defense, Trebesska 1575, Hradec Kralove, Czech Republic. bajgar@pmfhk.cz
520    9_
$a Prophylactic approaches against intoxication with organophosphates (OP)/nerve agents can be based on following principles: keeping acetylcholinesterase (AChE), the key enzyme for toxic action of OP/nerve agents, intact (protection of cholinesterases) is a basic requirement for effective prophylaxis. It can be reached using simple chemicals such as reversible inhibitors (preferably carbamates), which are able to inhibit AChE reversibly. AChE inhibited by carbamates is resistant to OP/nerve agent inhibition. After spontaneous recovery of the activity, normal AChE serves as a source of the active enzyme. Detoxification is realised by administration of the enzymes splitting the OP or exploitating specific enzymes (cholinesterases). OP/nerve agent is bound to the exogenously administered proteins (enzymes) and, thus, the agent level in the organism is decreased ("scavenger" effect). The antidotes currently used for the treatment of OP poisoning (also simple chemicals) can be tested as prophylactics. This principle can be considered as a treatment "in advance". The problem with their use is the timing, duration and achievement of sufficient levels of these antidotes after the administration. At present, PYRIDOSTIGMINE seems to be common prophylactic antidote; prophylactics PANPAL (tablets with pyridostigmine, trihexyphenidyle and benactyzine), TRANSANT (transdermal patch containing HI-6) are other means introduced into different armies as prophylactics. Future development will be focused on scavengers (cholinesterases and other enzymes) acting before the binding of nerve agent to the target sites, and on other drugs reversible cholinesterase inhibitors (e.g. huperzine A, physostigmine, acridine derivatives etc.) including non-traditional routes of administration.
590    __
$a bohemika - dle Pubmed
650    _2
$a acetylcholinesterasa $x chemie $x metabolismus $7 D000110
650    _2
$a chemické bojové látky $x chemie $x otrava $7 D002619
650    _2
$a cholinergní antagonisté $x farmakologie $x chemie $7 D018680
650    _2
$a cholinesterasové inhibitory $x farmakologie $x chemie $x otrava $7 D002800
650    _2
$a reaktivátory cholinesterasy $x farmakologie $x chemie $7 D002801
650    _2
$a lidé $7 D006801
650    _2
$a organofosfáty $x chemie $7 D010755
650    _2
$a otrava $x prevence a kontrola $7 D011041
650    _2
$a otrava organofosfáty $7 D062025
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Fusek, Josef, $d 1945- $7 nlk20000076283
700    1_
$a Kassa, Jiří, $d 1956- $7 mzk2003181395
700    1_
$a Kuča, Kamil, $d 1978- $7 xx0041831
700    1_
$a Jun, Daniel, $d 1976- $7 xx0040498
773    0_
$t Current Medicinal Chemistry $w MED00001274 $g Roč. 16, č. 23 (2009), s. 2977-2986 $x 0929-8673
910    __
$a ABA008 $b x $y 2
990    __
$a 20110802092945 $b ABA008
991    __
$a 20121127124130 $b ABA008
999    __
$a ok $b bmc $g 881841 $s 732914
BAS    __
$a 3
BMC    __
$a 2009 $b 16 $c 23 $d 2977-2986 $m Current medicinal chemistry $n Curr Med Chem $i 0929-8673 $x MED00001274
LZP    __
$a 2011-4B09/jvme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...